Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
The ATTACC, ACTIV-4a, and REMAP-CAP Investigators
[Article] New England Journal of Medicine. 385(9):790-802, August 26, 2021.

(Format: HTML, PDF)